A prospective study of whole-body MRI (WBMRI) as part of a multimodality screening program for individuals with Li-Fraumeni syndrome (LFS).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Asaf Maoz, Nan Chen, Puja J. Umaretiya, Sophie Cahill, Alison Schwartz Levine, Jyothi Priya Jagannathan, Stephan D. Voss, Danielle Novetsky Friedman, Michael Francis Walsh, Mark E. Robson, Bita Nehoray, Megan Frone, Katherine Schneider, Jaclyn Schienda, Lisa Diller, Junne Kamihara, Huma Q. Rana, Judy Ellen Garber, Wendy London, Allison Frances O'Neill
Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Mass General Brigham, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, The University of Texas Southwestern Medical Center, Boston Children's Hospital, Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, National Institutes of Health, Division of Cancer Epidemiology and Genetics
Language: English
Topic: MRI in cancer diagnosis
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410817856